University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Proceedings of the 8th Vertebrate Pest
Conference (1978)

Vertebrate Pest Conference Proceedings
collection

March 1978

RODENTICIDAL ACTIVITY OF BROMADIOLONE—A NEW
ANTICOAGULANT
Adrian P. Meehan
Chief Biologist, Rentokil Limited, Felcourt, East Grinstead, Sussex, England

Follow this and additional works at: https://digitalcommons.unl.edu/vpc8
Part of the Environmental Health and Protection Commons

Meehan, Adrian P., "RODENTICIDAL ACTIVITY OF BROMADIOLONE—A NEW ANTICOAGULANT" (1978).
Proceedings of the 8th Vertebrate Pest Conference (1978). 31.
https://digitalcommons.unl.edu/vpc8/31

This Article is brought to you for free and open access by the Vertebrate Pest Conference Proceedings collection at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Proceedings of the 8th
Vertebrate Pest Conference (1978) by an authorized administrator of DigitalCommons@University of Nebraska Lincoln.

RODENTICIDAL ACTIVITY OF BROMADIOLONE—A NEW ANTICOAGULANT
ADRIAN P. MEEHAN, Chief Biologist, Rentokil Limited, Felcourt, East Grinstead, Sussex, England

ABSTRACT: Bromadiolone, a new anticoagulant rodenticide, has been evaluated against laboratory rats
and mice. Kill of both species was excellent, even when bromadiolone was offered for only one day in
the presence of alternative food. Effectiveness against homozygous warfarin resistant rats was also
demonstrated. Limited field trials on farms showed that after baiting for seven days with bromadiolone,
warfarin resistant rat populations were substantially reduced although subsequent re-infestation
occurred. Longer or continuous periods of baiting with bromadiolone would almost certainly prevent
population increase, but government restrictions on the amount of bait approved for the trials did not
allow this to be demonstrated.
INTRODUCTION
The introduction of anticoagulants stands out as the major development in rodent control in the
last twenty-five years. But in 1958, a population of Rattus norvegicus, in Scotland, became resistant
to the most commonly used anticoagulant, warfarin (Boyle 1960) - a problem which was subsequently
recognized in other parts of Britain. Since then anticoagulant resistance has been found in a number of
rodent species in various parts of the world, including the U.S.A. This has been well-documented and
Kaukeinen (1977) has produced an extensive bibliography. Generally there has been cross-resistance, to
a greater or lesser degree, to all of the more established anticoagulants.
Recently, however, new anticoagulants with the ability to control these resistant animals have
been synthesized. The first to be marketed was difenacoum and Bull (1976) has reviewed the properties
of this anticoagulant. More recently, Rennison and Dubock (1978) have field tested brodifacoum, an
analogue of difenacoum.
Bromadiolone, is another similar type compound, which is also capable of controlling warfarin
resistant rats and mice. Marsh (1976) and Grand (1976) have shown that bromadiolone has activity
against a wide range of rodents, including gophers, ground squirrels, various "field" mice and voles.
Bromadiolone is a hydroxy coumarin with the full chemical name: - 4 - hydroxy - 3 - coumarinyl 3 - phenyl - 3, 4 - bromo 4 - biphenyl, - 1 - proponal - 1 (Fig. 1).

Fig. 1. Structure of bromadiolone.
Bromadiolone acts as a classical indirect anticoagulant, i.e. it interferes with Vitamin K activity,
but its potency is about 10 times greater than that of warfarin in rabbits (Grand loc. cit.). This
author also describes laboratory and field tests with bromadiolone against rats carried out in France.
The present paper gives details of tests with bromadiolone against laboratory strains of Rattus
norvegicus and Mus musculus particularly in feeding tests. Preliminary results from field trials in
England against warfarin resistant R. norvegicus are also given.
MATERIALS AND METHODS Laboratory Studies
T.O. mice and Wistar rats were used for both the oral dosing and feeding studies. Mice weighed
approximately 24-26g and rats 150-200g and equal numbers of males and females were used in all tests.
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Homozygous warfarin resistant rats were bred by ourselves from a small number originally
obtained from the laboratories of Ward-Blenkinsop Limited.
Acute Oral Toxicity
Bromadiolone was administered to groups of ten mice and rats as a suspension in 0.6% gum tragacanth
at five concentrations ranging from 0.2-3.2mg/kg. The dose was administered in 0.5ml of the suspension
to mice and in 1.0ml to rats. Gum tragacanth alone was used as control. LD 50’S were determined by the
method of Weil (1952).
Feeding Studies
The feeding tests were of two types - the "no-choice" test and "paired preference" test.
The "no-choice" test involves feeding a poisoned bait alone and is designed simply to assess the
toxicity of a rodenticide when incorporated in a bait. Likewise this is the primary objective of the
"paired preference" test, but this also measures the relative acceptance of a similar unpoisoned
(alternative) food, when offered in competition with the poisoned bait.
In both types of test, bromadiolone was formulated in a medium oatmeal/sugar base at 0.0025%,
0.005% and 0.01%, with a small amount of oil as a binder. The alternative food, when provided, was
medium oatmeal/sugar. As a basis for comparison, a proprietary formulation of warfarin at 0.05% on
whole wheat, BiotrolR, was used. Each concentration of test bait was offered to groups of twenty mice,
caged in pairs, and to ten rats caged singly, with or without alternative food.
Food consumption was assessed daily and hopper positions alternated to avoid place preference.
After one, two and four days the experimental diets were replaced with a standard laboratory diet.
Kill was scored for at least 14 days after the diets containing bromadiolone were withdrawn.
Water was available at all times. The mean ambient temperature was 20°C ±_2°C and the relative
humidity varied between 40% and 60%.
A "paired preference" test against rats and mice was also carried out with a liquid concentrate
of bromadiolone impregnated into whole wheat at 0.005%. This formulation was also tested against
homozygous warfarin resistant rats in comparison with the standard warfarin formulation. Only four
rats could be used in each test because of the small numbers available.
Field Trials Against Rattus norvegicus
It was not possible to carry out tests against wild rodents in the laboratory, but a small number
of preliminary field trials have been completed.
Eight sites infested with Rattus norvegicus in the warfarin resistant area of Kent and Sussex,
England were used. All the premises were farms and all had a long-standing rat control problem.
Before the start of the trial, a bait containing 0.05% warfarin was laid daily for 7 days at each
site. Large quantities of this bait were taken by rats and census baiting and visual observations
showed that large numbers survived the treatment, confirming their resistance to warfarin. Bromadiolone,
at 0.005% on whole wheat, was then laid at each site for seven days. This was followed by a posttreatment census.
All census treatments were with unpoisoned oatmeal. A "rest period" of 1 week was interposed
between all poison and census treatments to avoid "pre-baiting".
Takes of bait from each baiting point were assessed daily and where necessary, baits were
replenished. When a bait was completely taken, twice the amount was replaced. A numerical system
of measuring "takes" was used as weighing was impractical.
RESULTS AND DISCUSSION
Laboratory Studies - Acute Oral Toxicity
Bromadiolone is somewhat more toxic to males than females (Table 1). It is also somewhat more
toxic to the strains used by Rentokil than those tested by Grand (loc. cit.) who determined an acute
oral LD50 of 1.125mg/kg for rats and of 1.75mg/kg for mice. The difference may also be due to the
vehicle used for administering bromadiolone.
Laboratory Studies - Mortality
Kill of the test animals was good, and far superior to that found with warfarin baits. Only the
occasional animal survived. Mice (Table 2) appeared somewhat more tolerant than rats (Table 3) but
this is experienced with most anticoagulants.
The feeding regime made little difference to results: kill was similar whether alternative food
was present or not and regardless of the number of days poison was fed. It would therefore appear that
in the laboratory, bromadiolone is capable of killing rats and mice after feeding for only one night
even at concentrations as low as 0.0025%. This supports the results of Marsh's work with Norway rats
in one day “no. choice” tests.
123

Table 1. The acute oral toxicity of bromadiolone (mg/kg) to rats and mice when orally dosed.

Table 2. Food consumption and kill of T.O. mice offered bromadiolone or warfarin with and without
alternative food.

The interval between feeding and death was not influenced significantly by any parameter, including
the amount of poison eaten. The mean time to death is more than 6 days for both rats and mice and only
one animal (a mouse) died in less than four days. Some animals continued to die up to 15 days from the
start of experiments.
The smallest amount of bromadiolone eaten was by the test group of animals given the lowest
concentration of bromadiolone for one day only. This was 3 and 2mg/kg respectively for mice and rats,
but was still well in excess of the respective LD50'S. Excellent kill was achieved at even these levels.
The number of homozygous resistant rats fed in the laboratory was small. However, when bromadiolone
was fed to these, three out of four were killed, whereas warfarin failed to kill any. This indicates
that even highly resistant individuals such as these are capable of being controlled by bromadiolone.
Grand (loc. cit.) also states that bromadiolone is active against resistant rats.
Palatability
The palatability of bromadiolone to both rats and mice was excellent when incorporated with an
oatmeal base (Tables 2 and 3). Baits offered to mice contained a small amount of oil as a binder, and
it was probably this which made the poison material many times more palatable than the untreated
alternative.
At the two lowest concentrations used, rats are unable to detect bromadiolone and in fact preferred
the treated diet. At the highest concentration (0.01%), rats could just detect the bromadiolone,
whereas mice even at this level, continued to eat more treated diet than alternative.
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Table 3. Food consumption and kill of Wistar rats offered bromadiolone or warfarin in an oatmeal
base with and without alternative food.

Table 4. Food consumption and kill of Wistar rats and T.O. mice offered 0.005% bromadiolone formulated
on whole wheat and fed in competition with alternative food.
Mean active
ingredient
intake
(mg/kg)

Amount eaten (g)
Days
1 2

3

K i ll

Days to Death
Mean

Range

4

Wistar
Rats

Poison
Alt

163 128
275 373

103
284

84
208

5

20/20

5.8

4-9

T.O.
Mice

Poison
Alt

65 42
21 43

17
72

19
58

25

19/20

7.5

4-15

Changing the bait base to wheat (Table 4) slightly reduced the palatability of bromadiolone to
both rats and mice, but it was still more palatable than warfarin in similar baits. But despite the
somewhat reduced palatability excellent kills were obtained viz. 100% and 95% for rats and mice,
respectively.
Field Trials
The tests were carried out in and around farm buildings in the autumn/winter of 1977. The results
from all eight sites were similar: progress at three, typical sites is therefore reported (Fig. 2).
After seven days baiting with 0.005% bromadiolone the rat populations judged by the takes of bait
were minimal at all the three sites. An average reduction of over 90%. This was confirmed by visual
observation and live trapping. However, after a 7 day interval without bait and a further 7 days posttreatment census with oatmeal, the populations again appeared to increase. This was caused by reinfestation of the treated buildings from surrounding land - a common occurrence in rural areas,
particularly where food and harborage is sought by rats in the autumn. The amount of bait approved by
the U.K. government (MAFF) for these trials was limited. Thus if sufficient bait had been available to
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Figure 2. Intake of 0.005% bromadiolone bait
and unpoisoned oatmeal post treatment census bait on three typical
farms infested with warfarin
resistant R. norvegicus. (There is
a seven day delay between the treatment and census).

leave it down for longer periods or continuously, complete control would have been obtained. Rennison
and Dubock (loc. cit.) made similar conclusions when testing brodifacoum. One, four and seven-day feeds
gave only partial control, whereas baiting for up to 25 days gave complete control.
No untoward health incidents occurred during the tests with bromadiolone and none have been
reported from France, where more widespread trials have been conducted. More extensive trials with
bromadiolone are planned as soon as Government clearance is obtained.
The greatest poisoning risk with rodenticides is to cats and dogs in the U.K. The toxicity of
bromadiolone to these animals is lower than that of warfarin. The maximum tolerated single oral dose
to dogs is lOmg/kg and to cats 25mg/kg. A dog would thus have to eat 20% of its body weight of 0.005%
bait before clinical symptoms appear. The chronic toxicity to pigs is significantly lower than that of
warfarin, but strangely bromadiolone is more toxic to chickens. Bromadiolone would thus seem to present
no greater hazard in use, than other anticoagulants.
CONCLUSIONS
Bromadiolone clearly shows potential as a replacement for warfarin and other anticoagulants which
require repeated feedings to kill. It is active against resistant rats and has a good safety margin to
most non-target species. The optimum conditions of use by pest control personnel in the U.K. has
now to be documented.
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